Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights
Go back to Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights| (NASDAQ: ADVM) | Delayed: 4.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.36 | 52 Week High | $4.86 | |||
| Open | $4.36 | 52 Week Low | $2.74 | |||
| Day High | $4.36 | P/E | N/A | |||
| Day Low | $4.36 | EPS | $0.00 | |||
| Volume | 219 | |||||

